Estimating cost savings from reducing antibiotic overprescription in european general practices
Fabiana Raynal Floriano·Carl Llor·Marilena Anastasaki·Athina Chalkidou·Pascale Bruno·Bent Håkan Lindberg·Jette Nygaard Jensen·Ingrid Keilegavlen Rebnord·Daniela Modena·Jonas Olsen·Maria Hansen·Katja Taxis·Vanessa Lesage·Stella Mally·Jesper Lykkegaard·Malene Plejdrup Hansen·Laura Vallejo-Torres·B. Gonzalez Lopez-Valcarcel·Lars Bjerrum·Ruta Radzeviciene·Lina Jaruseviciene·Maria -Nefeli Karkana·Maciej Godycki–Cwirko·Ana García-Sangenís·Pia Touboul-Lundgren·Marina Elistratova·Maarten Lambert·Jens Søndergaard·Laura Álvarez·Anna Kowalczyk·Christos Lionis
Antibiotic (ATB) overprescription leads to antimicrobial resistance (AMR) and adverse events (AEs) and poses significant economic burdens on European healthcare systems. The aim of this study was to assess the economic impact associated with interventions aimed at reducing unnecessary ATB prescriptions in general practice, and to extrapolate the results at the European Union (EU) level. We used data from the “HAPPY PATIENT” project, a before-and-after study that implemented a multifaceted interv